De-Escalation Has Lasting Benefits for HER2+ Breast Cancers
If diagnosed at an early stage, HER2-positive tumors have a good prognosis and can be treated with less aggressive and less toxic chemotherapies.
Medscape Medical News
source https://www.medscape.com/viewarticle/990456?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/990456?src=rss
Comments
Post a Comment